STOCKHOLDERS’ EQUITY - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Number of Shares
Outstanding at beginning of period (in shares)	651,269
Granted (in shares)	0	0
Exercised (in shares)	(166,634)
Canceled (in shares)	0
Outstanding at end of period (in shares)	484,635		651,269
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 7.37
Granted (in dollars per share)	0
Exercised (in dollars per share)	6.25
Canceled (in dollars per share)	0
Outstanding at end of period (in dollars per share)	$ 7.75		$ 7.37
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Vested and Expected to Vest (in shares)	484,635
Exercisable (in shares)	484,635
Vested and Expected to Vest, Weighted-Average Exercise Price (in dollars per share)	$ 7.75
Exercisable, Weighted-Average Exercise Price (in dollars per share)	$ 7.75
Outstanding, Weighted-Average Remaining Contractual Terms (in Years)	4 years 2 months 12 days		3 years 7 months 6 days
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term (in Years)	4 years 2 months 12 days
Exercisable, Weighted-Average Remaining Contractual Term (in Years)	4 years 2 months 12 days
Outstanding, Aggregate Intrinsic Value	$ 1,440		$ 2,185
Exercised, Aggregate Intrinsic Value	833
Vested and Expected to Vest, Aggregate Intrinsic Value	1,440
Exercisable, Aggregate Intrinsic Value	$ 1,440